Bret Weinstein

So it's a great way of making a drug look not very effective.

And a lot of people are overweight.

Absolutely.

So on this plot, every, so you see those horizontal lines, you've got a box in the middle of a bunch of horizontal lines.

The horizontal lines are confidence intervals.

if they don't touch the 1.0 line, then the result is statistically significant.

So in all of these categories, ivermectin is statistically significant in its efficacy.

In the one category where it's not, it's still effective.

It's just not statistically significant in its effectiveness.

And they buried this in this appendix, page 346.

And actually, can you scroll down to the next tweet in this thread?

Can you, let's see, click on the link to the paper.

Now scroll down.

Let's get a background.

Method.

Stop.

Go back up a little bit.

Interpretation.

So this is their take-home message from the paper.

It says, Ivermectin for COVID-19 is unlikely to provide a clinically meaningful improvement in recovery, hospital admissions, or longer-term outcomes.